Don't agree for one second. There has been zero discussion on dividend to this stage as growth is the focus to become dominant in more markets than it is at present.... and growth is going remarkably well thank you very much. No wonder when every single surgeon that has tried BTM has become a convert with the superior results and lower cost that it gives them...... not to mention experienced sales staff jumping ship to join the good ship Polynovo.
Hope that helps.![]()
- Forums
- ASX - By Stock
- PNV
- Ann: FY23 Results Presentation
PNV
polynovo limited
Add to My Watchlist
0.00%
!
$1.22

Ann: FY23 Results Presentation, page-41
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
0.000(0.00%) |
Mkt cap ! $839.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 86 | $1.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 19 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 86 | 1.330 |
11 | 1591 | 1.290 |
8 | 187 | 1.280 |
3 | 3528 | 1.255 |
1 | 5 | 1.235 |
Price($) | Vol. | No. |
---|---|---|
1.120 | 19 | 1 |
1.140 | 7 | 2 |
1.155 | 541 | 2 |
1.200 | 1 | 1 |
1.205 | 1381 | 5 |
Last trade - 10.01am 18/06/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online